{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:06:38Z","timestamp":1719187598548},"reference-count":11,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Heron Therapeutics, Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.2217\/fon-2019-0835","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T10:29:27Z","timestamp":1580120967000},"page":"263-268","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective study"],"prefix":"10.1080","volume":"16","author":[{"given":"Toni S","family":"Perry","sequence":"first","affiliation":[{"name":"Varian Medical Systems,\rNashville,\rTN\r37203,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Dickson","sequence":"additional","affiliation":[{"name":"Tennessee Oncology,\rNashville,\rTN\r37203,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey F","family":"Patton","sequence":"additional","affiliation":[{"name":"Tennessee Oncology,\rNashville,\rTN\r37203,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"Cinvanti (aprepitant) injectable emulsion for intravenous use prescribing information. Heron Therapeutics CA USA (2019)."},{"key":"e_1_3_4_4_1","unstructured":"American Society of Health-System Pharmacists and University of Utah Drug Information Service\n. Small-volume parenteral solutions shortages suggestions for management and conservation (2017). www.fda.gov\/media\/108408\/download"},{"key":"e_1_3_4_5_1","unstructured":"NCCN clinical practice guidelines in oncology: antiemesis \u2013 version 1.2019. www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf"},{"key":"e_1_3_4_6_1","unstructured":"Emend (fosaprepitant) for injection for intravenous use prescribing information. Merck & Co NJ USA (2019)."},{"key":"e_1_3_4_7_1","unstructured":"Varubi (rolapitant) tablets for oral use. Varubi (rolapitant) injectable emulsion for intravenous use prescribing information. Tesaro Inc MA USA (2018)."},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0577"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S155875"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0311"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S201609"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/NAN.0000000000000341"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61024-1"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2019-0835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:46:02Z","timestamp":1719125162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2019-0835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.2217\/fon-2019-0835"],"URL":"https:\/\/doi.org\/10.2217\/fon-2019-0835","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-12-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}